MATCH IT!® Antibody Analysis Software
Streamline Your Data Analysis.
Streamline Your Data Analysis
MATCH IT! Antibody, a software designed specifically to simplify the complexities of HLA Antibody analysis.
Evaluate results from the LIFECODES Antibody products.
- CREG group highlighting
- Built In epitope tail analysis
- Advanced highlight and overlay tools to help determine antibody specificity
- Detailed graphing features
- Various reporting options and formats
- Clear and easy results interpretation
MATCH IT! Antibody software is FDA cleared and CE marked for in vitro diagnostic use.
Resource Library
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Our Certifications
Related Products
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....
News & Blogs
Werfen Introduces NanoTYPE® HLA-11 Plus — First RUO HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the launch of NanoTYPE® HLA-11 Plus, a...
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary,...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion...
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
